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Wo Laughing Matter
epression is a serious condition that we now know affects both
he body and the mind. As such, we are troubled by the response
f Ziegelstein et al. (1) to the American Heart Association Science
dvisory’s recommendation for screening for depression in cardiac
atients (2). To ridicule and dismiss the legitimate recommenda-
ion for depression screening with a “Never Mind” was disappoint-
ng to those of us involved in the clinical care of patients with
oronary disease. It is well established that depression: 1) is
specially common in a variety of cardiac patient populations; 2) is
ssociated with a worse prognosis independent of disease severity
nd other risk factors; 3) is associated with nonadherence and
eightened medical expenditures; and 4) is associated with im-
aired quality of life (3). The claim that “discussing whether they
ave symptoms of depression” is different from screening for
epression is a distinction that is likely to escape most readers and
onveys a message that recognizing depression is not important in
he care of patients with heart disease.
So why would Ziegelstein et al. (1) object to efforts to identify
atients with depressive symptoms? One reason is their claim that
here is little evidence that treating depression is effective. Nothing
s further from the truth. There are a number of empirically
alidated therapies for treating depression ranging from cognitive
ehavior therapy to pharmacotherapy (4), and there is no evidence
hat these therapies are any less effective in cardiac patients
ompared with the general population of depressed patients. Not
nly is there abundant evidence that depression can be successfully
reated, it is also noteworthy that physicians routinely assess risk
actors that are not modifiable (i.e., age and family history) to
valuate patients’ total burden of cardiac risk. Comprehensive risk
actor assessment is common in medical practice and may prompt
ore aggressive treatment of other risk factors that can be
avorably altered.
Another objection raised by Ziegelstein et al. (1) is that there
re insufficient data to claim that the benefits of screening for
epression outweigh the harm. However, they fail to provide any
vidence of the harm in assessing depression in the context of a
ardiologic examination. They point to the “stigma” of depression,
et their position actually serves to stigmatize the very patients they
laim to be concerned about. The last thing that patients need to
ear after having a heart attack is that not only are their hearts
amaged, but that their mental health also may be impaired. We
ave long advocated that the traditional “mental health approach”
o treating cardiac patients is less likely to be effective and may be
ounterproductive (5). We believe that the treating physician is in
n ideal position to normalize patients’ feelings, monitor their
epressive symptoms, and prescribe additional treatments when
ecessary. Although Ziegelstein et al. (1) suggest that depressive
creening is expensive and could burden the health care system,
hey provide no basis for this assertion and the claim that
hysicians lack the time, expertise, or resources is an inadequate
ationalization. oThe American Heart Association Science Advisory guidelines
ere not intended to provide specific instructions for how clini-
ians should assess depression, but rather were intended to provide
linicians with one possible approach that could be useful in their
linical practices. Instruments such as the Patient Health Ques-
ionnaire could provide physicians with a starting point for the
discussion” that Ziegelstein et al. (1) recommend. Although the
atient Health Questionnaire is simple, brief, inexpensive, and
asy to administer, there are other instruments and approaches that
ave been widely used in cardiac patients and are equally cost
ffective. For example, instruments such as the Beck Depression
nventory show acceptable sensitivity and specificity, although, as
ith most screening tools, self-report instruments are not meant to
eplace clinical judgment. The point is that physicians need to be
ognizant of depressive symptoms in their patients and take
hatever steps are necessary to monitor and treat as needed.
Finally, although we agree with Ziegelstein et al. (1) that there
s little evidence currently available that treating depression results
n improved clinical outcomes (i.e., reduced mortality and mor-
idity), there are ongoing studies that are examining this issue.
egardless of the impact on medical outcomes, however, depres-
ion is no joke—and the benefits of treating depression on quality
f life should be taken seriously.
James A. Blumenthal, PhD
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e agree with Drs. Blumenthal and O’Connor in their response to
ur paper (1) that depression is “no laughing matter” and suspect
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February 23, 2010:836–9hat they agree with us that when caring for patients with coronary
eart disease (CHD), clinicians should inquire about symptoms of
epression, as they should about symptoms of other serious health
onditions. Where we disagree is regarding the matter of routine
epression screening. Whereas Drs. Blumenthal and O’Connor
uggest that the American Heart Association (AHA) Science
dvisory (2) was “not intended to provide specific instructions” for
ssessing depression, the Science Advisory recommendation for
routine screening for depression in patients with CHD” is
nambiguous.
We agree with Drs. Blumenthal and O’Connor that “the
reating physician is in an ideal position to normalize patients’
eelings, monitor their depressive symptoms, and prescribe addi-
ional treatments when necessary.” Routine depression screening,
owever, is altogether different. In fact, it need not involve a
onversation between the treating physician and the patient at all.
outine depression screening involves having all individuals with
HD complete a questionnaire and then referring those who have
score above a threshold for a more comprehensive assessment (3).
In the course of their practice, physicians are often asked
hether patients with multiple cardiovascular risk factors should
e screened for CHD with a cardiac stress test, even if they do not
ave CHD symptoms. After all, CHD is common among those
ith risk factors, and the disease causes significant morbidity and
ortality. So why does the AHA not recommend a cardiac stress
est either for the routine screening of asymptomatic men or
omen or for those with multiple risk factors (4)? The AHA
cientific Statement on exercise testing in asymptomatic adults (5)
xplains, “Screening for serious chronic diseases is a complex topic.
utside the realm of large randomized trials, it is arguably
mpossible to definitively determine whether screening has any real
enefit. Although it makes intuitive sense to diagnose disease at a
tage before it causes major clinical events, screening may actually
e harmful.”
We recognize that there are differences between screening for
epression and coronary disease, but it is not clear what difference
ight make routine screening recommended in the first instance
nd not in the second. One thing for sure is that it is not the
eriousness of the health issue at hand, and it is surprising that
nyone familiar with our work might conclude that the humor
sed in our editorial (1) suggests that we believe that depression is
ot a serious medical condition. In any case, the use of humor to
ommunicate a point that challenges prevailing opinion is not the
ssue. The issue is whether the AHA Science Advisory on
epression screening was based on evidence, and, unfortunately,
he authors of the Advisory did not conduct the type of careful
eview of benefits and harms of depression screening that is
ustomary for this type of statement. Just 1 month after the
dvisory was issued, a systematic review was published that found
o evidence that screening would improve depression outcomes
mong patients with CHD (6). Beyond this, no randomized,
ontrolled trial in any patient group has compared patients
creened for depression with patients not screened for depression,
ll else equal, and found that screening results in improved
epression outcomes. At least 11 such trials in primary care, as well
s trials in perinatal care and cancer, found negative results (7).Drs. Blumenthal and O’Connor believe that our claim that a
ifference exists between having physicians discuss symptoms of
epression with their patients in the context of their relationship
nd routine screening is “a distinction that is likely to escape most
eaders.” We doubt that. However, their claim that “The AHA
cience Advisory guidelines were not intended to provide specific
nstructions for how clinicians should assess depression” is not
hat readers will conclude from that document.
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